摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-十二烷基-2-氰基乙酰胺 | 35942-43-9

中文名称
N-十二烷基-2-氰基乙酰胺
中文别名
——
英文名称
2-cyano-N-dodecylacetamide
英文别名
N-dodecyl-2-cyanoacetamide;2-cyanoacetyldodecylamine;N-dodecylcyanoacetamide;Cyanessigsaeure-dodecylamid
N-十二烷基-2-氰基乙酰胺化学式
CAS
35942-43-9
化学式
C15H28N2O
mdl
——
分子量
252.4
InChiKey
DLZXGOYWWWFMCZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    421.8±28.0 °C(Predicted)
  • 密度:
    0.916±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    5
  • 重原子数:
    18
  • 可旋转键数:
    12
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.87
  • 拓扑面积:
    52.9
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    参考文献:
    名称:
    A New Quadruply Bound Heterodimer DDAD·AADA and Investigations into the Association Process
    摘要:
    DOI:
    10.1002/1099-0690(200212)2002:23<4054::aid-ejoc4054>3.0.co;2-h
  • 作为产物:
    描述:
    十二烷基伯胺氰乙酸甲酯三乙胺 作用下, 以 乙酸乙酯 为溶剂, 反应 48.0h, 生成 N-十二烷基-2-氰基乙酰胺
    参考文献:
    名称:
    Design of a novel thiophene inhibitor of 15-lipoxygenase-1 with both anti-inflammatory and neuroprotective properties
    摘要:
    The enzyme 15-lipoxygenase-1 (15-LOX-1) plays a dual role in diseases with an inflammatory component. On one hand 15-LOX-1 plays a role in pro-inflammatory gene expression and on the other hand it has been shown to be involved in central nervous system (CNS) disorders by its ability to mediate oxidative stress and damage of mitochondrial membranes under hypoxic conditions. In order to further explore applications in the CNS, novel 15-LOX-1 inhibitors with favorable physicochemical properties need to be developed. Here, we present Substitution Oriented Screening (SOS) in combination with Multi Component Chemistry (MCR) as an "effective strategy to identify a diversely substituted small heterocyclic inhibitors for 15-LOX-1, denoted ThioLox, with physicochemical properties superior to previously identified inhibitors. Ex vivo biological evaluation in precision-cut lung slices (PCLS) showed inhibition of pro-inflammatory gene expression and in vitro studies on neuronal HT-22 cells showed a strong protection against glutamate toxicity for this 15-LOX-1 inhibitor. This provides a novel approach to identify novel small with favorable physicochemical properties for exploring 15-LOX-1 as a drug target in inflammatory diseases and neurodegeneration. (C) 2016 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2016.07.010
点击查看最新优质反应信息

文献信息

  • PROCESS FOR PREPARING SUBSTITUTED PYRIDONE COMPOUNDS
    申请人:Xerox Corporation
    公开号:US20040006234A1
    公开(公告)日:2004-01-08
    Disclosed is a process for preparing substituted pyridone compounds which comprises (a) admixing in the absence of a solvent (1) an amine of the formula R 1 —NH 2 wherein R 1 is an alkyl group, an aryl group, an arylalkyl group, or an alkylaryl group, and (2) a first ester of the formula 1 wherein R 2 is an electron withdrawing group and R 3 is an alkyl group; (b) heating the mixture containing the amine and the first ester to form an intermediate compound of the formula 2 (c) admixing the intermediate compound with (1) a base and (2) a second ester of the formula 3 wherein R 4 is an alkyl group, an aryl group, an arylalkyl group, or an alkylaryl group and R 5 is an alkyl group, said second ester being present in a molar excess relative to the intermediate compound, said base being present in a molar excess relative to the intermediate compound, and (d) heating the mixture containing the intermediate compound, the second ester, and the base to form a pyridone compound of the formula 4 or a salt thereof. Also disclosed is a process for preparing diazopyridone colorants which comprises preparing a pyridone compound by the above process and reacting the pyridone compound with a diazonium salt to form a diazopyridone compound.
    揭示了一种制备取代吡啶酮化合物的过程,包括(a)在无溶剂的情况下混合(1)具有R1—NH2式的胺,其中R1是烷基、芳基、芳基烷基或烷基芳基,以及(2)具有R2为电子吸引基团和R3为烷基的第一酯的混合;(b)加热含有胺和第一酯的混合物以形成具有式2的中间化合物;(c)将中间化合物与(1)碱和(2)具有R4为烷基、芳基、芳基烷基或烷基芳基以及R5为烷基的第二酯混合,其中所述第二酯相对于中间化合物存在摩尔过量,所述碱相对于中间化合物存在摩尔过量,并且(d)加热含有中间化合物、第二酯和碱的混合物以形成具有式4的吡啶酮化合物或其盐。还揭示了一种制备重氮吡啶酮染料的过程,包括通过上述过程制备吡啶酮化合物,并将吡啶酮化合物与重氮盐反应以形成重氮吡啶酮化合物。
  • 齐聚噻吩衍生物电致变色材料及其制备方法
    申请人:华南理工大学
    公开号:CN107011318B
    公开(公告)日:2019-05-14
    本发明公开了齐聚噻吩衍生物电致变色材料及其制备方法;齐聚噻吩衍生物电致变色材料具有如下的分子结构:n=1‑3,m=5‑18。本发明分别以噻吩齐聚物三噻吩、六噻吩、九噻吩为原料,通过Vilsmeier‑Haack反应在上述三种齐聚噻吩的末端引入两个醛基;氰基乙酸先经过酯化,再与烷基胺反应生成2‑氰基乙酰烷基胺;将上述二步反应的产物通过Knoevenagel缩合得到目标产物。本发明所制备的齐聚噻吩衍生物可以形成凝胶,用凝胶作为电致变色材料所制备的器件,不需要成膜的工艺,而且还可能解决由于使用液体电解质而容易使器件发生漏夜的问题。
  • Synthesis, Biological Evaluation, and Molecular Docking of 8-imino-2-oxo-2<i>H</i>,8<i>H</i>-pyrano[2,3-<i>f</i>]chromene Analogs: New Dual AChE Inhibitors as Potential Drugs for the Treatment of Alzheimer's Disease
    作者:Jeelan Basha Shaik、Bhagath Kumar Palaka、Mohan Penumala、Siddhartha Eadlapalli、Manidhar Darla Mark、Dinakara Rao Ampasala、Ramakrishna Vadde、Damu Amooru Gangaiah
    DOI:10.1111/cbdd.12732
    日期:2016.7
    approach should therefore address more than one target. In line with this modern paradigm, a series of 8‐imino‐2‐oxo‐2H,8H‐pyrano[2,3‐f]chromene analogs (4a–q) were synthesized and evaluated for their multitarget‐directed activity on acetylcholinesterase, butyrylcholinesterase (BuChE), 2,2’‐azino‐bis(3‐ethylbenzthiazoline‐6‐sulfonic acid) (ABTS) radical, and amyloid‐β peptide (Aβ) specific targets for Alzheimer's
    阿尔茨海默氏病的发作和发展与多种复杂生理过程的失调有关,因此成功的治疗方法应解决多个目标。根据这种现代范式,合成了一系列8-亚氨基-2-氧代-2 H,8 H-吡喃[2,3- f ]色烯类似物(4a – q)并评估了它们在多靶点上的活性。乙酰胆碱酯酶,丁酰胆碱酯酶(BuChE的),2,2'-连氮基-双(3-乙基苯并噻唑-6-磺酸)(ABTS)基团,和淀粉样蛋白β肽(A β)阿尔茨海默氏病治疗的特定目标。大多数合成的化合物在低n m浓度下表现出显着的乙酰胆碱酯酶抑制活性,并具有良好的ABTS自由基清除活性,但是,没有BuChE抑制活性的证据。其中,3-溴苄酰胺衍生物4m表现出最好的乙酰胆碱酯酶抑制活性,IC 50值为13±1.4 n m,是参比药物加兰他敏的51倍。动力学和分子对接研究表明4m是混合型抑制剂,同时与乙酰胆碱酯酶的催化活性和外围阴离子位点结合。五种化合物4e,4f,4g,4j和4k的抗氧化活性比trolox高1
  • Easy Synthesis of Two Positional Isomeric Tetrazole Libraries
    作者:Alexander Dömling、Yuanze Wang、Pravin Patil
    DOI:10.1055/s-0035-1562435
    日期:——
    Abstract A fast and efficient synthesis of libraries of positional isomeric 1H-tetrazoles and 5H-tetrazoles, for the purpose of testing binding hypothesis of isomeric tetrazoles in fragment-based drug discovery, is described. A fast and efficient synthesis of libraries of positional isomeric 1H-tetrazoles and 5H-tetrazoles, for the purpose of testing binding hypothesis of isomeric tetrazoles in fragment-based
    摘要 为了测试基于片段的药物发现中的异构四唑的结合假设,描述了位置异构体1 H-四唑和5 H-四唑的文库的快速有效合成。 为了测试基于片段的药物发现中的异构四唑的结合假设,描述了位置异构体1 H-四唑和5 H-四唑的文库的快速有效合成。
  • Dimerization of Merocyanine Dyes. Structural and Energetic Characterization of Dipolar Dye Aggregates and Implications for Nonlinear Optical Materials
    作者:Frank Würthner、Sheng Yao、Tony Debaerdemaeker、Rüdiger Wortmann
    DOI:10.1021/ja020168f
    日期:2002.8.1
    Aggregation of polar merocyanine dyes has been identified as an important problem in the fabrication of organic materials for photonic applications. In this work, a series of merocyanine dyes is synthesized, and their aggregation is investigated by a combination of several experimental techniques to reveal structure-property relationships. These studies provide clear evidence for the formation of centrosymmetric
    极性部花青染料的聚集已被确定为制造用于光子应用的有机材料中的一个重要问题。在这项工作中,合成了一系列部花青染料,并通过多种实验技术的组合研究了它们的聚集,以揭示结构-性能关系。这些研究为所有研究的部花青在浓溶液和固态中形成中心对称二聚体提供了明确的证据。通过浓度相关的介电常数测量、紫外-可见光谱和光电吸收实验研究液体溶液中二聚的热力学。通过 2D NMR 光谱在溶液中以及通过 X 射线晶体学在固态中观察到具有偶极矩反平行排序的中心对称二聚体结构,并根据偶极和 pi-pi 相互作用进行解释。激子耦合模型可以令人满意地解释二聚体聚集体的光学特性。考虑外部电场对二聚平衡的影响并通过电光吸收测量定量确定。讨论了观察到的发现对非线性光学和光折变材料设计的影响。考虑外部电场对二聚平衡的影响并通过电光吸收测量定量确定。讨论了观察到的发现对非线性光学和光折变材料设计的影响。考虑外部电场对二聚平衡的影响并通
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物